Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux

NCT00369265 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
18
Enrollment
OTHER
Sponsor class

Stopped Pharmaceutical company purchased by another company and funding was terminated.

Conditions

Interventions

Sponsor

American Institute for Voice and Ear Research